financetom
Business
financetom
/
Business
/
Brown & Brown signs $9.8 billion deal for rival broker Accession Risk
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brown & Brown signs $9.8 billion deal for rival broker Accession Risk
Jun 10, 2025 4:21 AM

(Reuters) -Insurance broker Brown & Brown ( BRO ) will buy Risk Strategies parent Accession Risk Management in a $9.83 billion deal, the companies announced on Tuesday.

The deal adds to a handful of mega transactions in the highly fragmented insurance broker industry in recent years, as top firms look to increase scale and boost their competitive position.

It is expected to close in the third quarter of 2025.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Freshworks Insider Bought Shares Worth $1,994,166, According to a Recent SEC Filing
Freshworks Insider Bought Shares Worth $1,994,166, According to a Recent SEC Filing
Nov 13, 2025
03:53 AM EST, 11/13/2025 (MT Newswires) -- Tyler Sloat, Chief Financial & Operating Officer, on November 11, 2025, executed a purchase for 171,615 shares in Freshworks ( FRSH ) for $1,994,166. Following the Form 4 filing with the SEC, Sloat has control over a total of 1,149,244 Class A common shares of the company, with 1,149,244 shares held directly. SEC...
Halozyme Therapeutics Insider Sold Shares Worth $4,167,930, According to a Recent SEC Filing
Halozyme Therapeutics Insider Sold Shares Worth $4,167,930, According to a Recent SEC Filing
Nov 13, 2025
03:56 AM EST, 11/13/2025 (MT Newswires) -- Helen Torley, Director, President and Chief Executive Officer, on November 10, 2025, sold 60,000 shares in Halozyme Therapeutics ( HALO ) for $4,167,930. Following the Form 4 filing with the SEC, Torley has control over a total of 733,719 common shares of the company, with 733,719 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1159036/000115903625000054/xslF345X05/wk-form4_1762991674.xml ...
Carvana Insider Sold Shares Worth $3,250,300, According to a Recent SEC Filing
Carvana Insider Sold Shares Worth $3,250,300, According to a Recent SEC Filing
Nov 13, 2025
03:55 AM EST, 11/13/2025 (MT Newswires) -- Ryan S. Keeton, Chief Brand Officer, on November 10, 2025, sold 10,000 shares in Carvana ( CVNA ) for $3,250,300. Following the Form 4 filing with the SEC, Keeton has control over a total of 104,958 Class A common shares of the company, with 104,958 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1690820/000170054225000011/xslF345X05/wk-form4_1762991500.xml ...
Adaptive Biotechnologies Insider Sold Shares Worth $1,315,180, According to a Recent SEC Filing
Adaptive Biotechnologies Insider Sold Shares Worth $1,315,180, According to a Recent SEC Filing
Nov 13, 2025
03:54 AM EST, 11/13/2025 (MT Newswires) -- Chad M Robins, Director, Chief Executive Officer and Chairman, on November 10, 2025, sold 89,265 shares in Adaptive Biotechnologies ( ADPT ) for $1,315,180. Following the Form 4 filing with the SEC, Robins has control over a total of 2,869,975 common shares of the company, with 2,869,975 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1478320/000178064925000002/xslF345X05/primary_doc.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved